SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001694665-20-000058
Filing Date
2020-06-18
Accepted
2020-06-18 17:14:17
Documents
2
Period of Report
2020-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159251484038936.html 4  
1 FORM 4 wf-form4_159251484038936.xml 4 4131
2 POWER OF ATTORNEY (NANCY A. SIMONIAN) ex-24.htm EX-24 3696
  Complete submission text file 0001694665-20-000058.txt   9238
Mailing Address C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Simonian Nancy A (Reporting) CIK: 0001359574 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38473 | Film No.: 20973508

Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Issuer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations